Sign up to save your podcasts
Or
Share The role of biomarker testing in NSCLC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The role of biomarker testing in NSCLC
touchMDT for touchONCOLOGY
Listen to a medical oncologist and a pathologist discuss the evolving role of biomarker testing in NSCLC in the light of emerging testing methodologies and treatment targets.
The multidisciplinary team
- Medical oncologist: Dr Alexander Drilon, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-navigating-diagnosis-and-treatment-nsclc/
View all episodes
By touchpodcasttouchMDT for touchONCOLOGY
Listen to a medical oncologist and a pathologist discuss the evolving role of biomarker testing in NSCLC in the light of emerging testing methodologies and treatment targets.
The multidisciplinary team
- Medical oncologist: Dr Alexander Drilon, USA
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-navigating-diagnosis-and-treatment-nsclc/